A Study to Evaluate Long-term Safety and Clinical Activity of Givosiran (ALN-AS1) in Patient With Acute Intermittent Porphyria (AIP)
Clinical trial NCT02949830 · COMPLETED
Trial details
- NCT number
- NCT02949830
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2021-11-05
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.